Zelmac Cost Analysis Data Could Define Use - Committee Member
Executive Summary
Maintenance studies for Novartis' Zelmac should include a cost analysis component, FDA Gastrointestinal Drugs Advisory Committee member Michael Wolfe, MD, said June 26.